Anoro Ellipta® Inhaler for COPD Maintenance Treatment

What Anoro Ellipta® Is and How It Works

The Anoro Ellipta Inhaler is a once-daily dry powder inhaler used for maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It contains umeclidinium and vilanterol. This dual bronchodilator opens airways by relaxing smooth muscle and blocking muscarinic receptors. It is not for sudden breathing problems and not indicated for asthma.

Youdrugstore is a licensed Canadian pharmacy headquartered in Manitoba, and pharmacists review prescriptions before dispensing. The manufacturer of Anoro Ellipta is GSK (GlaxoSmithKline). The labeled strength is anoro 62.5 mcg/25 mcg per inhalation (umeclidinium 62.5 mcg and vilanterol 25 mcg). You may see it listed as anoro 62.5 25, anoro 62.5 ellipta, or as anoro umeclidinium vilanterol.

Each dose is delivered as umeclidinium and vilanterol inhalation powder via the Ellipta device. This is a breath-activated dry powder, not a spray or aerosol canister. The mechanism provides bronchodilation through a LAMA/LABA combination. Use one inhalation once daily at the same time each day. Talk with a clinician if symptoms are not controlled; do not increase the dose on your own.

We also partner with licensed, audited international pharmacies to source authentic brands across a wide range at more affordable prices.

Dosage and Usage

Below are practical anoro ellipta instructions and device steps. This summarizes the dosage for anoro ellipta and anoro inhaler how to use guidance. Always follow the patient leaflet that comes with your device.

• Standard anoro ellipta dose: 1 inhalation (62.5/25 mcg) once daily.
• Do not take more than 1 inhalation in 24 hours.
• Prepare the dose: slide the cover down until it clicks. The counter will count down by 1.
• Exhale fully away from the device. Do not exhale into the mouthpiece.
• Place the mouthpiece between your lips and create a tight seal.
• Inhale steadily and deeply. The device releases the powder as you breathe in.
• Remove the inhaler and hold your breath for 3–4 seconds, then breathe out slowly.
• Close the cover after use. No priming or shaking is needed.
• Missed dose: take the next dose at the usual time the next day. Do not double.
• Keep a rescue inhaler available for sudden symptoms. Anoro Ellipta is not for relief of acute bronchospasm.
• Do not use with other long-acting beta agonists (LABAs) or other long-acting muscarinic antagonists (LAMAs).
• Ask your clinician how many puffs: the usual answer is one inhalation once daily.

Storage and travel tips for the Anoro Ellipta dry powder inhaler:

• Store at 20–25 °C (68–77 °F); excursions 15–30 °C (59–86 °F).
• Keep in the foil tray until first use. Write the opening date on the label.
• Discard 6 weeks after opening or when the counter reads 0, whichever comes first.
• Keep dry. Do not wash or immerse the device. Wipe the mouthpiece with a dry tissue.
• Do not store in a bathroom. Avoid heat, direct sunlight, and freezing.
• When flying, keep the inhaler in your carry-on. Keep the cover closed to protect from moisture.
• Keep away from children and pets. Do not use if the device is damaged.

Benefits and Savings

Anoro Ellipta helps improve lung function and breathlessness in adults with COPD. Many people notice smoother daily breathing and fewer flare-ups over time. Once-daily dosing is simple. The Ellipta device is ready to use, with no canister to shake or spacer to attach. The labeled anoro ellipta ingredients are umeclidinium and vilanterol, with lactose as an excipient.

Ordering from Youdrugstore can lower costs. Savings often reach 60–80% compared with typical US cash prices. Multi-month supplies may reduce your per-month cost. You can set gentle reorder reminders so you do not run out. For extra deals, see anoro ellipta coupons.

Side Effects and Safety

• Common side effects of anoro ellipta inhaler: sore throat, runny or stuffy nose, cough, headache.
• Dry mouth or constipation from the anticholinergic component.
• Muscle cramps, tremor, or nervousness.
• Fast heartbeat or palpitations.
• Urinary retention or difficulty urinating, especially in men with BPH.
• Eye pain, blurred vision, or halos (possible narrow‑angle glaucoma).
• Nausea, diarrhea, or upper respiratory infection symptoms.
• Local throat irritation or hoarseness.

Serious reactions are uncommon but can include paradoxical bronchospasm, severe allergic reaction (including anaphylaxis or angioedema), significant cardiovascular effects, severe urinary retention, worsening narrow‑angle glaucoma, or severe hypersensitivity to milk proteins (the powder contains lactose). Combining with insulin or sulfonylureas does not usually cause hypoglycemia, but beta agonists may affect blood sugar and potassium. Get emergency help for sudden breathing trouble after dosing.

Onset Time

Many patients feel easier breathing after the first dose, often within 15 minutes. Peak bronchodilation for a dose is typically within a few hours. Lung function improvements build over the first 1–2 weeks as daily dosing continues. Symptom control and reduction in COPD exacerbations often become clearer over several weeks of stable use. Keep using it once daily unless your prescriber advises changes.

Compare With Alternatives

Several maintenance options exist for COPD. Other LAMA/LABA combinations include tiotropium/olodaterol (Stiolto Respimat) and glycopyrrolate/formoterol (Bevespi Aerosphere). These offer similar once- or twice-daily bronchodilation with different inhaler devices and dosing schedules.

Some patients need an inhaled corticosteroid (ICS) added if they have frequent exacerbations or elevated eosinophils. An ICS/LABA such as budesonide/formoterol or fluticasone combinations may be considered. You can review an ICS option like Flovent® Hfa for controller therapy in asthma; ICS can be used in selected COPD cases.

Short-acting options can be used as needed in COPD for relief. An anticholinergic such as Atrovent® Inhaler (ipratropium) or a short-acting beta agonist (SABA) helps manage sudden symptoms. Triple therapy products that add an ICS to a LAMA/LABA, such as fluticasone/umeclidinium/vilanterol, are also available when indicated.

Combination Therapy

• Anoro Ellipta with a SABA (for example, albuterol) as a rescue inhaler for acute symptoms.
• Anoro Ellipta with an inhaled corticosteroid in patients with frequent COPD exacerbations.
• Avoid using with other long-acting muscarinic antagonists or long-acting beta agonists to prevent overdose.
• Monitor for cardiovascular effects when used with other sympathomimetics.
• Review medications that can lower potassium; beta agonists may reduce serum potassium.

Patient Suitability and Cost-Saving Tips

Anoro Ellipta is for adults with COPD who need maintenance bronchodilation. It should not be used for asthma. Long-acting beta agonists increase the risk of asthma-related problems when used without an ICS, and Anoro Ellipta is not indicated for asthma at all. It does not replace a rescue inhaler.

People with severe milk protein allergy should not use this inhaler because it contains lactose. Use caution if you have narrow‑angle glaucoma, urinary retention, prostate enlargement, heart rhythm problems, hyperthyroidism, seizures, or uncontrolled hypertension. Discuss pregnancy or breastfeeding with your clinician. Do not start, stop, or change therapy without medical advice.

To manage costs, compare the cost of anoro ellipta across package sizes. A 3‑month supply can lower the per‑month price. Bulk promotions may apply at checkout. You can turn on reorder reminders in your account so you refill on time. We offer brand and generic medicines at Canadian prices, and ordering is available online or by phone during office hours.

Authoritative Sources

See the manufacturer’s product details on the GSK Anoro Ellipta HCP site, the full US labeling in the FDA Prescribing Information, and the Canadian monograph via the Health Canada Drug Product Database.

Order Anoro Ellipta® from Youdrugstore: add to cart, upload your prescription, and we ship with prompt, express, cold-chain handling.

This page is educational and does not replace medical advice from your healthcare professional. Always follow your prescriber’s instructions and the patient leaflet in your package.